Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chris Pepper

Showing results (1-10 of 114) with videos related to

Pageof 12
Sort By:
Blood|July 10, 2010
Targeting the "partners in crime"Chris Pepper
Leukemia Research|May 26, 2009
APRIL showers put a spring in the step of CLL cellsChris Pepper
Blood|October 25, 2008
Suppressing the tumor suppressor in CLL?Chris Pepper
The Lancet. Oncology|February 2, 2015
Understanding cancer cell survival is key to patient survivalChris Fegan, Chris Pepper
Blood|February 5, 2011
CLL: a supplementary question?Chris Pepper, Chris Fegan
Advances in Experimental Medicine and Biology|September 10, 2013
Apoptosis deregulation in CLLChris Fegan, Chris Pepper
British Journal of Haematology|March 13, 2019
Is venetoclax a new wonder drug in CLL?Chris Fegan, Chris Pepper
Future Oncology (London, England)|December 15, 2010
Shortened telomeres: a driving force behind leukemia?Chris Pepper, Duncan M Baird
Current Opinion in Genetics & Development|March 30, 2020
Clinical utility of telomere length measurements in cancerChris Pepper, Kevin Norris, Christopher Fegan
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|August 27, 2013
Reducing inappropriate ENT referralsSridhayan Mahalingam, Chris Pepper, Pippa Oakeshott
Pageof 12

Showing results (1-10 of 114) with videos related to

Sort By:
Pageof 12
Blood|July 10, 2010
Targeting the "partners in crime"Chris Pepper
Leukemia Research|May 26, 2009
APRIL showers put a spring in the step of CLL cellsChris Pepper
Blood|October 25, 2008
Suppressing the tumor suppressor in CLL?Chris Pepper
The Lancet. Oncology|February 2, 2015
Understanding cancer cell survival is key to patient survivalChris Fegan, Chris Pepper
Blood|February 5, 2011
CLL: a supplementary question?Chris Pepper, Chris Fegan
Advances in Experimental Medicine and Biology|September 10, 2013
Apoptosis deregulation in CLLChris Fegan, Chris Pepper
British Journal of Haematology|March 13, 2019
Is venetoclax a new wonder drug in CLL?Chris Fegan, Chris Pepper
Future Oncology (London, England)|December 15, 2010
Shortened telomeres: a driving force behind leukemia?Chris Pepper, Duncan M Baird
Current Opinion in Genetics & Development|March 30, 2020
Clinical utility of telomere length measurements in cancerChris Pepper, Kevin Norris, Christopher Fegan
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|August 27, 2013
Reducing inappropriate ENT referralsSridhayan Mahalingam, Chris Pepper, Pippa Oakeshott
Pageof 12